European mistletoe lectins have been recognized for their anticancer activity and ability to support quality of life for patients who are undergoing active treatment. With an excellent safety profile and the potential benefit for improved quality of life, many patients inquire about mistletoe as an integrative strategy alongside their conventional cancer plan.
Mistletoe is administered intravenously (IV) or subcutaneously (by injection), at a frequency determined by the prescribing physician based on your individual needs.
Offset side effects of conventional therapies
- Support blood counts
- Reduce tumor related pain
- Inhibit angiogenesis
- Support quality of life